volume 93, issue 3, P584-590 2015
DOI: 10.4269/ajtmh.15-0245
View full text
|
Sign up to set email alerts
|
Share

Abstract: Abstract. Long-term antimalarial chemoprophylaxis is currently used by deployed U.S. military personnel. Previous small, short-term efficacy studies have shown variable rates of side effects among patients taking various forms of chemoprophylaxis, though reliable safety and tolerability data on long-term use are limited. We conducted a survey of troops returning to Fort Drum, NY following a 12-month deployment to Operation Enduring Freedom, Afghanistan from 2006 to 2007. Of the 2,351 respondents, 95% reported…

Expand abstract